Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jankovic

Showing results (91-100 of 670) with videos related to

Pageof 67
Sort By:
Toxins|January 12, 2021
Botulinum Toxin in Movement Disorders: An UpdateCharenya Anandan, Joseph Jankovic
Clinical Parkinsonism & Related Disorders|July 28, 2021
Treatment of dystonia and ticsSteven Bellows, Joseph Jankovic
Clinical Neuropharmacology|March 15, 2019
Real-World Experience With VMAT2 InhibitorsNicki Niemann, Joseph Jankovic
Neurology. Clinical Practice|May 29, 2024
Extrapyramidal System/Symptoms/Signs Should Be RetiredAbhishek Lenka, Joseph Jankovic
Journal of Neurology|June 10, 2023
Real-world experience with VMAT2 inhibitors in Tourette syndromeKarim Makhoul, Joseph Jankovic
Journal of the Neurological Sciences|February 4, 2021
Parkinson's disease after COVID-19Karim Makhoul, Joseph Jankovic
Journal of the Neurological Sciences|September 25, 2007
Focal hand dystonia, mirror dystonia and motor overflowOraporn Sitburana, Joseph Jankovic
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 25, 2021
The Clinical Value of Patient Home Videos in Movement DisordersAndrew Billnitzer, Joseph Jankovic
Parkinsonism & Related Disorders|June 10, 2019
Young-onset Parkinson's disease: Its unique features and their impact on quality of lifeRaja Mehanna, Joseph Jankovic
Parkinsonism & Related Disorders|August 3, 2010
Respiratory problems in neurologic movement disordersRaja Mehanna, Joseph Jankovic
Pageof 67

Showing results (91-100 of 670) with videos related to

Sort By:
Pageof 67
Toxins|January 12, 2021
Botulinum Toxin in Movement Disorders: An UpdateCharenya Anandan, Joseph Jankovic
Clinical Parkinsonism & Related Disorders|July 28, 2021
Treatment of dystonia and ticsSteven Bellows, Joseph Jankovic
Clinical Neuropharmacology|March 15, 2019
Real-World Experience With VMAT2 InhibitorsNicki Niemann, Joseph Jankovic
Neurology. Clinical Practice|May 29, 2024
Extrapyramidal System/Symptoms/Signs Should Be RetiredAbhishek Lenka, Joseph Jankovic
Journal of Neurology|June 10, 2023
Real-world experience with VMAT2 inhibitors in Tourette syndromeKarim Makhoul, Joseph Jankovic
Journal of the Neurological Sciences|February 4, 2021
Parkinson's disease after COVID-19Karim Makhoul, Joseph Jankovic
Journal of the Neurological Sciences|September 25, 2007
Focal hand dystonia, mirror dystonia and motor overflowOraporn Sitburana, Joseph Jankovic
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|October 25, 2021
The Clinical Value of Patient Home Videos in Movement DisordersAndrew Billnitzer, Joseph Jankovic
Parkinsonism & Related Disorders|June 10, 2019
Young-onset Parkinson's disease: Its unique features and their impact on quality of lifeRaja Mehanna, Joseph Jankovic
Parkinsonism & Related Disorders|August 3, 2010
Respiratory problems in neurologic movement disordersRaja Mehanna, Joseph Jankovic
Pageof 67